| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 07/30/2008 | CN100406437C Amino alcohol derivatives or phosphonic acid derivatives and pharmaceutical compositions containing these |
| 07/30/2008 | CN100406436C Crystal forms of atorvastatin hemi-calcium and processes for preparing atorvastatin hemi-calcium forms IX |
| 07/30/2008 | CN100406427C Substituted phenylpropionic acid derivatives as agonists to human peroxisome proliferator-activated receptor alpha (ppar) |
| 07/30/2008 | CN100406005C Compound and method for therapeutic intervention in preventing diabetic complications |
| 07/30/2008 | CN100405920C Dried orange peel health-care tea |
| 07/29/2008 | US7405311 N-(trans-2,3-di-n-amyl-2-butenoic acid amide)-L-phenylglycinamide;treating hypertension, deficiency of magnesium ion bound to the plasma membranes of their somatic cells; sodium-sensitive essential hypertension and Type 2 insulin-resistant diabetes mellitus |
| 07/29/2008 | US7405307 N-(p-(2-alpha-carboxybenzylamino)ethylamino)phenyl)p-(p-trifluoromethylphenyl)benzamide; antiobesity and anti-type II diabetic agents |
| 07/29/2008 | US7405306 3-(2-alkoxycarbonyl-3-indolyl)-3-oxo-propionic acid ester or propionamide intermediates: methyl 3-[6-fluoro-2-(methoxycarbonyl)-1-methyl-1H-indol-3-yl]-3-oxopropanoate; peripheral neuropathy, Parkinson's disease, Alzheimer's disease |
| 07/29/2008 | US7405305 Pyrrole-2, 5dione derivatives and their used as GSK-3 inhibitors |
| 07/29/2008 | US7405226 Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses |
| 07/29/2008 | US7405225 Substituted 3-amino-thieno[2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses |
| 07/29/2008 | US7405217 N-aroyl piperazine derivatives as orexin receptor antagonists |
| 07/29/2008 | US7405196 administering a long acting insulin; also treating diabetic dyslipidemia and atherosclerosis in a patient with IFG, IGT or Type 2 diabetes, particularly early Type 2 diabetes |
| 07/29/2008 | US7404973 For use as dietary supplement, in drugs, soy protein concentrate |
| 07/29/2008 | US7404952 ATP-binding cassette transporter polypeptide which regulates metabolism of triglycerides; treatment of obesity and eating disorders |
| 07/29/2008 | US7404796 System for determining insulin dose using carbohydrate to insulin ratio and insulin sensitivity factor |
| 07/29/2008 | CA2515596C Cannabinoid receptor ligands and uses thereof |
| 07/29/2008 | CA2432222C Pyrazole compounds useful as protein kinase inhibitors |
| 07/29/2008 | CA2432132C Pyrazole compounds useful as protein kinase inhibitors |
| 07/29/2008 | CA2359592C Pharmaceutical compositions for alleviating discomfort |
| 07/29/2008 | CA2348742C Carbocyclic potassium channel inhibitors |
| 07/29/2008 | CA2333656C A novel vla-4 inhibitor: omepupa-v |
| 07/29/2008 | CA2286822C Kodaistatins a, b, c and d, a process for their production and their use |
| 07/29/2008 | CA2261835C Long-acting drugs and pharmaceutical compositions comprising them |
| 07/29/2008 | CA2218702C Fatty acid esters as bioactive compounds |
| 07/29/2008 | CA2175767C Adhesion receptor antagonists |
| 07/24/2008 | WO2008089310A2 Delta 5 desaturase inhibitors for the treatment of obesity |
| 07/24/2008 | WO2008089307A2 Delta 5 desaturase inhibitors for the treatment of pain, inflammation and cancer |
| 07/24/2008 | WO2008089281A2 Methods of treating diabetes |
| 07/24/2008 | WO2008089148A1 Method of treating a metabolic or neuropsychiatry disorder with a bh4 derivative prodrug |
| 07/24/2008 | WO2008089008A2 Tetrahydrobiopterin prodrugs |
| 07/24/2008 | WO2008088689A1 Substituted spirochromanone derivatives as acc inhibitors |
| 07/24/2008 | WO2008088688A1 Substituted spirochromanone derivatives as acc inhibitors |
| 07/24/2008 | WO2008088047A1 Method for glycosylation of flavonoid |
| 07/24/2008 | WO2008088030A1 Composition for prevention or treatment of disease associated with thrombus or embolus |
| 07/24/2008 | WO2008088006A1 Ap2 inhibitor |
| 07/24/2008 | WO2008087933A1 NOVEL INDOLE DERIVATIVE HAVING INHIBITORY ACTIVITY ON IϰB KINASE β |
| 07/24/2008 | WO2008087365A2 Substituted 1, 3-diphenylpropane derivatives, preparations and uses of same |
| 07/24/2008 | WO2008087198A1 Pharmaceutical composition comprising a pyrazole-o-glucoside derivative |
| 07/24/2008 | WO2008087190A2 Use of peptides in combination with surgical intervention for the treatment of obesity |
| 07/24/2008 | WO2008087030A1 Substituted pyrazoline compounds with acat inhibition activity, their preparation and use as medicaments |
| 07/24/2008 | WO2008086949A1 Use of substituted pyranone acid derivatives for the treatment of metabolic syndrome |
| 07/24/2008 | WO2008086854A1 5-([1,3,4] oxadiazol-2-yl)-1h-indazol and 5-([1,3,4] thiadiazol-2-yl)-1h-indazol derivatives as sgk inhibitors for the treatment of diabetes |
| 07/24/2008 | WO2008086716A1 Layered double hydroxide complex inserted by dipeptiven and the preparation method thereof |
| 07/24/2008 | WO2008068763A3 Mixture and method for reducing cholesterol using hydrophobic chitosan microparticles |
| 07/24/2008 | WO2008068424A3 Substituted 2,5-dihydro-3h-pyrazolo[4,3-c]pyridazin-3-one derivatives, preparation thereof and use of same as cannabinoid cb1 receptor ligands |
| 07/24/2008 | WO2008067257A3 Inhibitors of diacylglycerol o-acyltransferase type 1 enzyme |
| 07/24/2008 | WO2008066845A3 Treatment of metabolic syndrome with norfluoxetine |
| 07/24/2008 | WO2008060789A3 Use of spiro-oxindole compounds as therapeutic agents |
| 07/24/2008 | WO2008060190A3 Ligands of 5-ht6 receptors, a pharmaceutical composition, method for the production and use thereof |
| 07/24/2008 | WO2008055940A8 Combination therapy with sglt-2 inhibitors and their pharmaceutical compositions |
| 07/24/2008 | WO2008048691A3 Use of leptin for treating post-lipectomy ectopic fat deposition and other post-lipectomy associated disorders |
| 07/24/2008 | WO2008024497A3 INHIBITORS OF 11β -HYDROXYSTEROID DEHYDROGENASE TYPE 1 |
| 07/24/2008 | WO2008009125A9 Tetrahydro-5h-pyrido[2,3-d]azepines as 5-ht2c ligands |
| 07/24/2008 | US20080177082 N3 alkylated benzimidazole derivatives as mek inhibitors |
| 07/24/2008 | US20080177064 Dipeptidyl peptidase inhibitors |
| 07/24/2008 | US20080177036 Selective Linear Peptides with Melanocortin-4 Receptor (MC4-R) Agonist Activity |
| 07/24/2008 | US20080176950 Treatments Using Venlafaxine |
| 07/24/2008 | US20080176944 Elongase Genes and Uses Thereof |
| 07/24/2008 | US20080176936 e.g. 1,4-hydroxy-2(3aminophenyl)amide-3(4bromobenzyl)-5(carboxymethyl-oxymethyl)pyran; integrin receptor antagonist; antiproliferative, anticarcinogenic, antiinflammatory, antidiabetic agent; improved bioavailability |
| 07/24/2008 | US20080176924 Derivatives of 4,5-diarylpyrrole, preparation method thereof and use of same in therapeutics |
| 07/24/2008 | US20080176914 Crystal form of 2-(3-fluoro-4-hydroxyphenyl)-7-vinyl-1,3-benzoxazol-5-ol |
| 07/24/2008 | US20080176905 Polymorphic forms of rosiglitazone hydrobromide and processes for preparation thereof |
| 07/24/2008 | US20080176899 Such as 1-Benzo[1,3]dioxol-5-yl-cyclopropanecarboxylic acid [5-(2-methoxy-pyridin-3-ylmethyl)-thiazol-2-yl]-amide 5-(2-Methoxy-pyridin-3-ylmethyl)-thiazol-2-ylamine; cystic fibrosis transmembrane conductance regulator disorders |
| 07/24/2008 | US20080176890 Indazoles, benzothiazoles, and benzoisothiazoles, and preparation and uses thereof |
| 07/24/2008 | US20080176867 e.g., N-[[5-(4-bromophenyl)-4-(2,4-dichlorophenyl)pyrimidin-2-yl]methyl]-3-(trifluoromethyl)benzenesulfonamide; cannabinoid receptor modulator; metabolic and gastrointenstinal disorders, antidiabetic, antiinflammatory, analgesic agent; neurodegenerative diseases |
| 07/24/2008 | US20080176854 Nitro-Substituted Phenyl-Piperazine Compounds, Their Preparation and Use in Medicaments |
| 07/24/2008 | US20080176846 e.g. 3-(5-amino-2-methylphenyl)-7-chloro-1-methyl-1,6-naphthyridin-2(1H)-one; protein kinase inhibitor; antiinflammatory, anticarcinogenic, antiallergen, antidiabetic, antiischemic, hypotensive agent |
| 07/24/2008 | US20080176829 e.g. 2,5-methylene-9-(phenylsulfonyl)-1,2,3,4,5,9-hexahydro[1,5]oxazocino[3,2-e]indole; serotonin receptors antagonist or partial agonist; metabolic diseases, e.g. obesity, insulin resisitance, type 2 diabetes, eating disorders; antidepressant, anxiolytic agent; cosmetics |
| 07/24/2008 | US20080176822 Novel composition for treating metabolic syndrome |
| 07/24/2008 | US20080176819 with a water-insoluble cellulose derivative such as ethyl cellulose; cardiovascular disease or Type II diabetes |
| 07/24/2008 | US20080176804 Methods for Affecting Body Composition |
| 07/24/2008 | US20080176802 Methods of Use for Conjugated Exendin Peptides |
| 07/24/2008 | US20080176792 Vegfr-1 targeting peptides |
| 07/24/2008 | US20080175921 Once daily, low viscosity; very fine needle injectable suspension; pharmacokinetic performance |
| 07/24/2008 | US20080175907 Oral insulin therapies and protocol |
| 07/24/2008 | US20080175851 Methods and compositions for enhancing the growth of fish and shellfish |
| 07/24/2008 | US20080175837 Autophagy regulators; drug screening; dipeptidyl peptidase IV (Dpp4); preservative of organs for transplantation |
| 07/24/2008 | US20080175833 Using alpha -glucosidase administration to treat defects in glycogen synthesis or breakdown within muscles, liver and other cell types |
| 07/24/2008 | US20080175831 Neuroprotection by blood flow stabilization |
| 07/24/2008 | US20080175828 Proliferated cell lines and uses thereof |
| 07/24/2008 | US20080175795 e.g. 3-{4-[4-(2-amino-2-carbamoyl-ethyl)-phenoxy]-phenyl)-propionic acid; antiinflammatory and immunological diseases, cytokines (TNF- alpha , IL-1, IL-6), orexin, nitric oxide synthase inhibitor; obesity, hyperlipidemia, migraine, asthma, chronic obstructive pulmonary disease, osteoarthritis |
| 07/24/2008 | DE102007002717A1 Heterocyclische Indazolderivate Heterocyclic indazole derivatives |
| 07/24/2008 | CA2712109A1 Thiazolidine derivatives and methods for the preparation thereof |
| 07/24/2008 | CA2675836A1 Composition for preventing or treating thrombus- or embolus-associated disease |
| 07/24/2008 | CA2675735A1 5-(1,3,4-oxadiazol-2-yl)-1h-indazole and 5-(1,3,4-thiadiazol-2-yl)-1h-indazole derivatives as sgk inhibitors for the treatment of diabetes |
| 07/24/2008 | CA2675733A1 Method for glycosylation of flavonoid compounds |
| 07/24/2008 | CA2675442A1 Use of substituted pyranone acid derivatives for the treatment of metabolic syndrome |
| 07/24/2008 | CA2675134A1 Pterin analogs |
| 07/24/2008 | CA2674865A1 Indole derivative having i.kappa.b kinase .beta. inhibitory activity |
| 07/24/2008 | CA2674573A1 Substituted spirochromanone derivatives |
| 07/24/2008 | CA2674422A1 Composition and method of stabilized sensitive ingredient |
| 07/24/2008 | CA2673761A1 Substituted 3-phenyl-1-(phenylthienyl)propan-1-one and 3-phenyl-1-(phenylfuranyl)propan-1-one derivatives, and preparation and use of same |
| 07/23/2008 | EP1947111A1 Novel mucin glycoprotein and use thereof |
| 07/23/2008 | EP1947109A2 Biologically active peptides |
| 07/23/2008 | EP1947089A1 A-polymorph of a substituted pyrazoline, its preparation and use as medicaments |
| 07/23/2008 | EP1947088A1 Substituted pyrazoline compounds with ACAT inhibition activity, their preparation and use as medicaments |
| 07/23/2008 | EP1947085A1 Substituted indole sulfonamide compounds, their preparation and use as medicaments |
| 07/23/2008 | EP1946779A1 Combination of substituted pyrazolines and agent for treating dyslipidemia |
| 07/23/2008 | EP1946778A1 Active substance combination for the treatment of diabetes |